Chao Lü

机构：Nanjing University of Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Wuxi Taihu Hospital, Wuxi People's Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0002-1265-0903

发表论文 66 篇 · 总被引 1747 次 · h-index 19

代表论文

• MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT (2022 · Redox Biology · 被引 115)
• Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease (2021 · Carbohydrate Polymers · 被引 47)
• Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease (2022 · Chemical Engineering Journal · 被引 34)
• Caveolin-1 Alleviates Crohn’s Disease–induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1 (2022 · Inflammatory Bowel Diseases · 被引 23)
• Is Helicobacter pylori Infection Associated with Celiac Disease? A Meta-analysis (2022 · The Turkish Journal of Gastroenterology · 被引 19)
• CCR2/CCR5 antagonist cenicriviroc reduces colonic inflammation and fibrosis in experimental colitis (2024 · Journal of Gastroenterology and Hepatology · 被引 12)